T-2 toxin and apoptosis

Journal of Toxicologic Pathology

Volumn 19, Issue 1, 2006, Pages 15-27

  Doi, Kunio ^a   Shinozuka, Junko ^b   Sehata, Shinya ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

^c DAIICHI SANKYO CO   (Japan)

Author keywords

Apoptosis; Development; Mechanisms; Mice; Rat; T 2 toxin

Indexed keywords

EID: 33645469187     PISSN: 09149198     EISSN: 09149198     Source Type: Journal    
DOI: 10.1293/tox.19.15     Document Type: Review

References (117)

1. Desjardins AE, Hohn TM, and McCormick SP. Trichothecene biosynthesis in Fusariton species: chemistry, genetics, and significance. Microbiol Rev. 57: 595-604. 1993.
2. Nelson PE, Dignani MC, and Anaissie EJ. Taxonomy, biology, and clinical aspects of Fusarium species. Clin Microbiol Rev. 7: 479-504. 1994.
3. Yagen B and Bialer M. Metabolism and pharmacokinetics of T-2 toxin and related trichothecenes. Drug Metab Rev. 25: 281-323. 1993.
4. Bamburg JR, Riggs NV, and Strong FM. The structures of toxins from two strains of Fusarium tricinctum. Tetrahedron. 24: 3329-3336. 1968.
5. Joffe A. Toxicity of Fusarium poae and F. sporotrichiodes and its relation to alimentary aleukia. In: Mycotoxins. IFH Purchase (ed). Els. Scient. Publish. Comp., Amsterdam. 229-262. 1974.
6. Mirocha CJ. Effect of trichothecene mycotoxins on farm animals. In: Trichothecenes: Chemical, Biological and Toxicological Aspects. Y Ueno (ed). Kodansha Ltd., Tokyo. 177-194. 1983.
7. Ueno Y, Ishii K, Sakai Y, Kanaeda S, and Tsunoda H. Toxicological approaches to the metabolites of Fusaria. IV. Microbial survey on "bean-hulls poisoning of horses" with the isolation of toxic trichothecenes, neosolaniol and T-2 toxin of Fusarium solani M-1-1. Jpn J Exp Med. 42: 187-203. 1972.
8. Eriksen GS and Pettersson H. Toxicological evaluation of trichothecenes in animal feed. Animal Feed Science and Technology. 114: 205-239. 2004.
9. Stanford GK, Hood RD, and Hayes AW. Effect of prenatal administration of T-2 toxin to mice. Res Commun Chem Pathol Pharmacol. 10: 743-746. 1975.
10. Williams PP. Effects of T-2 mycotoxin on gastrointestinal tissues: a review of in vivo and in vitro models. Arch Environ Contam Toxicol. 18: 374-387. 1989.
11. IARC. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans series. In: IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Lyon, France. 467-488. 1993.
12. Sharma RP. Immunotoxicity of mycotoxins. J Dairy Sci. 76: 892-897. 1993.
13. Magnuson BA, Schiefer HB, Hancock DS, and Bhatti AR. Cardiovascular effects of mycotoxin T-2 after topical application in rats. Can J Physiol Pharmacol. 65: 799-802. 1987.
14. Lutsky I and Mor N. Experimental alimentary toxic aleukia in cats. Lab Anim Sci. 31: 43-47. 1981.
15. Matsumoto H, Ito T, and Ueno Y. Toxicological approaches to the metabolites of Fusaria. XII. Fate and distribution of T-2 toxin in mice. Jpn J Exp Med. 48: 393-399. 1978.
16. Corley RA, Swanson SP, Gullo GJ, Johnson L, Beasley VR, and Buck WB. Disposition of T-2 toxin, a trichothecene mycotoxin, in intravascularly dosed swine. J Agric Food Chem. 34: 868-875. 1986.
17. Beasley VR, Swanson SP, Corley RA, Buck WB, Koritz GD, and Burmeister HR. Pharmacokinetics of the trichothecene mycotoxin, T-2 toxin, in swine and cattle. Toxicon. 24: 13-23. 1986.
18. Coddington KA, Swanson SP, Hassan AS, and Buck WB. Enterohepatic circulation of T-2 toxin metabolites in the rat. Drug Metab Dispos. 17: 600-605. 1989.
19. Shiffin VI and Anderson P. Trichothecene mycotoxins trigger a ribotoxic stress response that activates c-jun N-terminal kinase and p38 mitogen-activated protein kinase and induces apoptosis. J Biol Chem. 274: 13985-13992. 1999.
20. Bennet JW and Klich M. Mycotoxins. Clin Microbiol Rev. 16: 497-516. 2003.
21. Thompson WL and Wannemacher RW Jr. In vivo effects of T-2 mycotoxin on synthesis of protein and DNA in rat tissues. Toxicol Appl Pharmacol. 105: 483-491. 1990.
22. Chang IM and Mar WC. Effect of T-2 toxin on lipid peroxidation in rats: elevation of conjugated diene formation. Toxicol Letts. 40: 275-280. 1988.
23. Eriksen GS, Pettersson H, and Lund H. Comparative cytotoxicity of deoxynivalenol, nivalenol, their acetylated derivatives and de-epoxy metabolites. Food Chem Toxicol. 42: 619-624. 2004.
24. Quiroga MA, Itagaki S, and Doi K. Early ultrastructural changes of thymocytes in T-2 toxicated mice. J Toxicol Pathol. 6: 109-112. 1993.
25. Shinozuka J, Li G, Kiatipattanasakul W, Uetsuka K, Nakayama H, and Doi K. T-2 toxin-induced apoptosis in lymphoid organs of mice. Exp Toxicol Pathol. 49: 387-392. 1997.
26. Gavrieli Y, Sherman Y, and Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 119: 493-501. 1992.
27. Shinozuka J, Suzuki M, Noguchi N, Sugimoto T, Uetsuka K, Nakayama H, and Doi K. T-2 toxin-induced apoptosis in hematopoietic tissues of mice. Toxicol Pathol. 26: 674-681. 1998.
28. Hayes MA and Schiefer HB. Comparative toxicity of dietary T-2 toxin in rats and mice. J. Appl. Toxicol. 2: 207-212. 1982.
29. Smith BJ, Holladay SD, and Blaylock BL. Hematopoietic alterations after exposure to T-2 mycotoxin. Toxicon. 32: 1115-1123. 1994.
30. Seifert MF and Marks SC Jr. The regulation of hemopoiesis in the spleen. Experimentia. 41: 192-199. 1985.
31. Shinozuka J and Doi K. T-2 toxin-induced apoptosis in the mouse lymphoid and hematopoietic; tissues. Mycotoxins. 53: 129-139. 2003.
32. Rosenstein Y and Lafarge-Frayssinet C. Inhibitory effect of Fusarium T2-toxin on lymphoid DNA and protein synthesis. Toxicol Appl. Pharmacol. 70: 283-288. 1983.
33. Velazco V, Faifer GC, and Godoy HM. Differential effects of T-2 toxin on bone marrow and spleen erythropoiesis in mice. Food Chem Toxicol. 34: 371-375. 1996.
34. Segal R, Milo-Goldzweig I, Joffe AZ, and Yagen B. Trichothecene-induced hemolysis. I. The hemolytic activity of T-2 toxin. Toxicol Appl Pharmacol. 70: 343-349. 1983.
35. DeLoach JR, Gyongyossy-Issa MI, and Khachatouriants GG. Species-specific hemolysis of erythrocytes by T-2 toxin. Toxicol Appl Pharmacol. 97: 107-112. 1989.
36. Gyongyossy-Issa. MI and Khachatourians GG. Interaction of T-2 toxin with murine lymphocytes. Biochem Biophys Acta. 803: 197-202. 1984.
37. Nagata T, Suzuki H, Ishigami N, Shinozuka J, Uetsuka Y, Nakayama H, and Doi K. Development of apoptosis and changes in lymphocyte subsets in thymus, mesenteric lymph nodes and Peyer's patches of mice orally inoculated with T-2 toxin. Exp Toxicol Pathol. 53: 309-315. 2001.
38. Shinozuka J, Li G, Uetsuka K, Nakayama H, and Doi K. Process of the development of T-2 toxin-induced apoptosis in the lymphoid organs of mice. Exp Anim. 46: 117-126. 1997b.
39. Smith BJ, Holladay SD, and Blaylock BL. Hematopoietic alterations after exposure to T-2 mycotoxins. Toxicon. 32: 1115-1123. 1994.
40. Islam Z, Nagase M, and Yoshizawa T. T-2 toxin induces thymic apoptosis in vivo in mice. Toxicol Appl Pharmacol. 148: 205-214. 1998.
41. Holladay SD, Smith BJ, and Luster MI. B lymphocyte precursor cells represent sensitive targets of T2 mycotoxin exposure. Toxicol Appl Pharmacol. 131: 309-315. 1995.
42. Shortman K, Egerton M, Spangrude GJ, and Scollay R. The generation and fate of thymocytes. Semin Immunol. 2: 3-12. 1990.
43. Holladay SD, Blaylock BL, Comment CE, Heindel JJ, and Luster MI. Fetal thymic atrophy after exposure to T-2 toxin: selectivity for lymphoid progenitor cells. Toxicol Appl Pharmacol. 121: 8-14. 1993.
44. Butcher EC, Rouse RV, Coffman RL, Nottenburg CN, Hardy RR, and Weissman IL. Surface phenotype of Peyer's patch germinal center cells: implications for the role of germinal centers in B cell differentiation. J Immunol. 129: 2698-2707. 1982.
45. Harriman GR, Kunimoto DY, Elliott JF, Paetkau V, and Strober W. The role of IL-5 in IgA B cell differentiation. J Immunol. 140: 3033-3039. 1988.
46. Weinstein PD and Cebra JJ. The preference for switching to IgA expression by Peyer's patch germinal center B cells is likely due to the intrinsic influence of their microenvironment. J Immunol. 147: 4126-4135. 1991.
47. Shinozuka J, Tsutsui S. Ishigami N, Ueno-Yamanouchi A, Nakayama H, and Doi K. Development of apoptosis and changes in apoptosis-related genes expression in the mouse thymus following T-2 toxin-inoculation. J Toxicol Pathol. 12: 77-81. 1999.
48. Alam MM, Nagase M, Yoshizawa T, and Sakato N. Thymocyte apoptosis by T-2 toxin in vivo in mice is independent of Fas/Fas ligand system. Biosci Biotechnol Biochem. 64: 210-213. 2000.
49. Verma IM, Mitchell RL, Kruijer W, Beveren CV, Zokas L, Hunter T and Cooper JA. Proto-oncogene c-fos: induction and regulation during growth and differentiation. Cancer Cells. 3: 275-287. 1985.
50. Lau LF and Nathans D. Expression of a set of growth-related immediate early genes in BALB/c 3T3 cells: coordinate regulation with c-fos or c-myc. Proc Natl Acad Sci. 84: 1182-1186. 1987.
51. Smeyne RJ, Vendrell M, Hayward M, Baker SJ, Miao GG, Schilling K. Robertson LM, Cuff an T, and Morgan JI. Continuous c-fos expression precedes programmed cell death in vivo. Nature. 363: 166-169. 1993.
52. Marti A, Jehn B, Costello E, Keon N, Ke G, Martin F, and Jaggi R. Protein kinase A and AP-1 (c-Fos/JunD) are induced during apoptosis of mouse mammary epithelial cells. Oncogene. 9: 1213-1223. 1994.
53. Mils V, Piette J, Barette C, Veyrune J, Tesniere A, Escot C, Guilhou JJ, and Basset-Seguin N. The proto-oncogene c-fos increases the sensitivity of keratinocytes to apoptosis. Oncogene. 14: 1555-1561. 1997.
54. Colotta F, Polentarutti N, Sironi M, and Mantovani A. Expression and involvement of c-fos and c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines. J Biol Chem. 267: 18278-18283. 1992.
55. Buttyan R, Zakeri Z, Lockshin R, and Wolgemuth D. Cascade induction of c-fos, c-myc, and heat shock 70K transcripts during repression of the rat ventral prostate gland. Mol Endocrinol. 2: 650-657. 1988.
56. Preston GA, Lyon TT, Yin Y, Lang JE, Solomon G, Annab L, Srinivasan DG, Alcorta DA, and Barrett JC. Induction of apoptosis by c-Fos protein. Mol Cell Biol. 16: 211-218. 1996.
57. Shinozuka J, Suzuki H, Tsutsui S, Nakayama H, and Doi K. T-2 toxin-induced apoptosis and c-fos mRNA expression in ConA-stimulated mouse thymocyte primary cultures. J Toxicol Pathol. 14: 247-251. 2001.
58. Morgan JI and Curran T. Calcium as a modulator of the immediate-early gene cascade in neurons. Cell Calcium. 9: 303-311. 1988.
59. i in induction of c-fas, c-jun and c-myc mRNA in rat PTE after oxidative stress. FASEB J. 6: 919-924. 1992.
60. 2+ and protein kinases in the induction of the hsp70 gene. Kidney Int. 45: 1093-1104. 1994.
61. Yoshino N, Takizawa M, Akiba H, Okumura H, Tashiro F, Honda M, and Ueno Y. Transient elevation of intracellular calcium ion levels as an early event in T-2 toxin-induced apoptosis in human promyelotic cell line HL-60. Nat Toxins. 4: 234-241. 1996.
62. Cohen DR and Curran T. The structure and function of the fos proto-oncogene. Crit Rev Oncog. 1: 65-88. 1989.
63. Nagase M, Alam MM, Tsushima A, Yoshizawa T, and Sakato N. Apoptosis induction by T-2 toxin: activation of caspase-9. caspase-3, and DFF-40/ CAD through cytosolic release of cytochrome c in HL-60 cells. Biosci Biotechnol Biochem. 65: 1741-1747. 2001.
64. Quiroga MA, Risso MA, Perfumo CJ, Idiart JR, Ohtsuka R, and Doi K. Sequence of and regional difference in apoptotic index in the mouse gastrointestinal mucous epithelia after T-2 toxin inoculation. J Toxicol Pathol. 13: 193-196. 2000.
65. Li G, Shinozuka J, Uetsuka K, Nakayama H, and Doi K. T-2 toxin-induced apoptosis in intestinal crypt epithelial cells oh mice. Exp Toxicol Pathol. 49: 447-450. 1997.
66. Li G, Shinozuka J, Uetsuka K, Nakayama H, and Doi K. T-2 toxin-induced apoptosis in Peyer's patches of mice. J Toxicol Pathol. 10: 59-61. 1997.
67. 3H] T-2 toxin adsorbed to corn dust. Food Chem Toxic. 22: 893-896. 1984.
68. 3H] T-2 toxin in rat model. J Toxicol Environ Health. 26: 413-423. 1989.
69. 3H] T-2 mycotoxin from abrasions. Toxicon. 28: 803-811. 1990.
70. Yarom R, Bergmann F, and Yagen B. Cutaneous injury by topical T-2 toxin: involvement of microvessels and mast cells. Toxicon. 25: 167-174. 1987.
71. Bhavanishankar TN, Ramesh HP, and Shantha T. Dermal toxicity of Fusarium toxins in combinations. Arch Toxicol. 61: 241-244. 1988.
72. Schiefer HB and Hancock DS. Systemic effects of topical application of T-2 toxin in mice. Toxicol Appl Pharmacol. 76: 464-472. 1984.
73. Blaylock BL, Kouchi Y, Comment CE, Pollock PL, and Luster MI. Topical application of T-2 toxin inhibits the contact hypersensitivity response in BALB/c mice. J Immunol. 150: 5135-5143. 1993.
74. Iwamoto S, Nakayama H, and Doi K. Morphological and morphometrical study on the dorsal skin of Wistar and WBN/ILA-Ht rats in their developing stage. Evaluation of the proliferation and apoptotic processes. Histol Histopathol. 13: 981-988. 1998.
75. Albarenque SM, Shinozuka J, Iwamoto S, Nakayama H, and Doi K. T-2 toxin-induced acute skin lesions in Wistar-derived hypotrichotic WBN/ ILA-Ht rats. Histol Histopathol. 14: 337-342. 1999.
76. Albarenque SM, Suzuki K, Shinozuka J, Nakayama H, and Doi K. Kinetics of apoptosis-related genes mRNAs expression in the dorsal skin of hypotrichotic WBN/ILA-Ht rats after topical application of T-2 toxin. Exp Toxicol Pathol. 52: 553-556. 2001.
77. Mils V, Piette J, Barette C, Veyrune J, Tesniere A, Escot C, Guilhou JJ, and Basset-Seguin N. The proto-oncogene c-fos increases the sensitivity of keratinocytes to apoptosis. Oncogene. 14: 1555-1561. 1997.
78. Shiffin V and Anderson P. Trichothecene mycotoxins trigger a ribotoxic stress response that activates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase and induces apoptosis. J Biol Chem. 274: 13985-13992. 1999.
79. + mimics ribotoxic stress. Inhibition of protein synthesis and activation of the stress kinases SEK1/MKK4, stress-activated protein kinase/c-Jun NH2-terminal kinase 1, and p38/HOG1 by palytoxin. J Biol Chem. 273: 3528-3534. 1998.
80. Albarenque SM, Shinozuka J, Suzuki K, Nakayama H, and Doi K. Kinetics and distribution of transforming growth factor (TGF)-β1 mRNA in the dorsal skin of hypotrichotic WBN/ILA-Ht rats following topical application of T-2 toxin. Exp Toxicol Pathol. 52: 297-301. 2000.
81. Benassi L, Ottani D, Fantini F, Marconi A, Chiodino C, Giannetti A, and Pincelli C. 1, 25-Dihydroxyvitamin D3, transforming growth factor (TGF)-β1, calcium, and ultraviolet B radiation induce apoptosis in cultured human keratinocytes. J Invest Dermatol. 109: 276-282. 1997.
82. Gruber BL, Marchese MJ, and Kew RR. Transforming growth factor-β1 mediates mast cell chemotaxis. J Immunol. 152: 5860-5867. 1994.
83. Kane CJ, Hebda PA, Mansbridge JN, and Hanawalt PC. Direct evidence for spatial and temporal regulation of transforming growth factor-β1 expression during cutaneous wound healing. J Cell Physiol. 148: 157-173. 1991.
84. Roberts AB, McCune BK and Sporn MB. TGF-beta: regulation of extracellular matrix. Kidney Int. 41: 557-559. 1992.
85. Albarenque SM, Suzuki K, Nakayama H, and Doi K. Kinetics of cytokines mRNAs expression in the dorsal skin of WBN/ILA-Ht rats following topical application of T-2 toxin. Exp Toxicol Pathol. 53: 271-274. 2001.
86. Köck A, Urbanski A, and Luger T. mRNA expression and release of tumor necrosis factor-α by human epidermal cells. J Invest Dermatol. 92: 462A. 1989.
87. Schwarz A, Bhardwaj R, Aragane Y, Mahnke K, Riemann H, Metze D, Luger TA, and Schwarz T. Ultraviolet-B-induced apoptosis of keratinocytes: evidence for partial involvement of tumor necrosis factor-alpha in the formation of sunburn cells. J Invest Dermatol. 104: 922-927. 1995.
88. Meng X, Sawamura D, Baba T, Ina S, Ita K, Tamai K, Hanada K, and Hashimoto I. Transgenic TNF-α causes apoptosis in epidermal keratinocytes after subcutaneous injection of TNF-α DNA plasmid. J Invest Dermatol. 113: 856-857. 1999.
89. Zhuang L, Wang B, Shinder GA, Shivji GM, Mak TW, and Sauder DN. TNF receptor p55 plays a pivotal role in murine keratinocyte apoptosis induced by ultraviolet B irradiation. J Immunol 162: 1440-1447. 1999.
90. Barker JN, Mitra RS, Griffiths CE, Dixit VM, and Nickoloff BJ. Keratinocytes as indicators of inflammation. Lancet. 337: 211-214. 1991.
91. Griffiths CE, Barker JN, Kunkel S, and Nickoloff BJ. Modulation of leucocyte adhesion molecules, a T-cell chemotaxin (IL-8) and a regulatory cytokine (TNF-α) in allergic contact dermatitis (rhus dermatitis). Br J Dermatol. 124: 519-526. 1991.
92. Nickoloff BJ and Naidu Y. Perturbation of epidermal barrier function correlates with inhibition of cytokine cascade in human skin. J Am Acad Dermatol. 30: 535-546. 1994.
93. Albarenque SM and Doi K. T-2 toxin-induced apoptosis in rat keratinocyte primary cultures. Exp Mol Pathol. 78: 144-149. 2005.
94. Lafarge-Frayssinet C, Chakor K, Lafont P, and Frayssinet C. Transplacentral transfer of T2-toxin: pathological effect. J Environ Pathol Toxicol Oncol. 10: 64-68. 1990.
95. Rousseaux CG and Schiefer HB. Maternal toxicity, embryolethality and abnormal fetal development in CD-1 mice following one oral dose of T-2 toxin. J Appl Toxicol. 7: 281-288. 1987.
96. Sehata. S, Teranishi M, Atsumi F, Uetsuka K, Nakayama H, and Doi K. T-2 toxin-induced morphological changes in pregnant rats. J Toxicol Pathol. 16: 59-65. 2003.
97. Sehata S, Kiyosawa N, Makino T, Atsumi F, Ito K, Yamato T, Teranishi M, Baba Y, Uetsuka K, Nakayama H, and Doi K. Morphological and microarray analysis of T-2 toxin-induced fetal brain lesion. Food Chem Toxicol. 42: 1727-1736. 2004.
98. Stanford GK, Hood RD, and Hayes AW. Effect of prenatal administration of T-2 toxin to mice. Res Commun Chem Pathol Pharmacol. 10: 743-746. 1975.
99. Hood RD, Kuczuk MH, and Szczech GM. Effects in mice of simultaneous prenatal exposure to ochratoxin A and T-2 toxin. Teratology. 17: 25-29. 1978.
100. O Khera KS. Maternal toxicity - a possible factor in fetal malformations in mice. Teratology. 29: 411-416. 1984.
101. Ishigami N, Shinozuka J, Katayama K, Nakayama H, and Doi K. Apoptosis in mouse fetuses from dams exposed to T-2 toxin at different days of gestation. Exp Toxicol Pathol. 52: 493-501. 2001.
102. Ishigami N, Shinozuka J, Katayama K, Uetsuka K, Nakayama H, and Doi K. Apoptosis in the developing mouse embryos from T-2 toxin-inoculated dams. Histol Histopathol. 14: 729-733. 1999.
103. Kniesel U, Risau W, and Wolburg H. Development of blood-brain barrier tight junctions in the rat cortex. Brain Res Dev Brain Res. 23: 229-240. 1996.
104. Ciriolo MR, De Martino A, Lafavia E, Rossi L, Carri MT, and Rotilio G. Cu,Zn-superoxide dismutase-dependent apoptosis induced by nitric oxide in neuronal cells. J Biol Chem. 275: 5065-5072. 2000.
105. Garrido C, Gurbuxani S, Ravagnan L, and Kroemer G. Heat shock proteins: endogenous modulators of apoptotic cell death. Biochem. Biophys Res Commun. 286: 433-442. 2001.
106. Hidalgo J, Aschner M, Zatta P, and Vasak M. Roles of the metallothionein family of proteins in the central nervous system. Brain Res Bull. 55: 133-145. 2001.
107. Ryter SW, Otterbein LE, Morse D, and Choi AM. Heme oxygenase/carbon monoxide signaling pathways: regulation and functional significance. Mol Cell Biochem. 234-235: 249-263. 2002.
108. Sastry PS and Rao KS. Apoptosis and the nervous system. J Neurochem. 74: 1-20. 2000.
109. Sehata S, Kiyosawa N, Atsumi F, Ito K, Yamato T, Teranishi M, Uetsuka K, Nakayama H, and Doi K. Microarray analysis of T-2 toxin-induced liver, placenta and fetal liver lesions in pregnant rats. Exp Toxicol Pathol. 57: 15-28. 2005.
110. Jarpe MB, Widmann C, Knall C, Schlesinger TK, Gibson S, Yujiri T, Fanger GR, Gelfand EW, and Johnson GL. Anti-apoptotic versus pro-apoptotic signal transduction: checkpoints and stop signs along the road to death. Oncogene. 17: 1475-1482. 1998.
111. Boldt S, Weidle UH, and Kolch W. The kinase domain of MEKK1 induces apoptosis by dysregulation of MAP kinase pathways. Exp Cell Res. 283: 80-90. 2003.
112. Ham J, Eilers A, Whitfield J, Nearne SJ, and Shah B. c-Jun and the transcriptional control of neuronal apoptosis. Biochem Pharmacol. 60: 1015-1021. 2000.
113. Shifrin VI and Anderson P. Trichothecene mycotoxins trigger a ribotoxic stress response that activates c-jun N-terminal kinase and p38 mitogen-activated protein kinase and induces apoptosis. J Biol Chem. 274: 13985-13992. 1999.
114. Yang GH, Jarvis BB, Chung YJ, and Pestka JJ. Apoptosis induction by the satratoxins and other trichothecene mycotoxins: relationship to ERK, p38 MAPK, and SAPK/JNK activation. Toxicol Appl Pharmacol. 164: 149-160. 2000.
115. Bond M, Murphy G, Bennett MR, Newby AC, and Baker AH. Tissue inhibitor of metalloproteinase-3 induces a Fas-associated death domain-dependent type II apoptotic pathway. J Biol Chem. 277: 13787-13795. 2002.
116. Cohen GM. Caspases: the executioners of apoptosis. Biochem J. 326: 1-16. 1997.
117. Annunziato L, Amoroso S, Pannaccione A, Cataldi M, Pignataro G, D'Alessio A, Sirabella R, Secondo A, Sibaud L, and Di Renzo GF. Apoptosis induced in neuronal cells by oxidative stress: role played by caspases and intracellular calcium ions. Toxicol Lett. 139: 125-133. 2003.